ATE302019T1 - Verfahren und zusammensetzungen zur optimierung des sauerstofftransportes in zellfreien systemen - Google Patents
Verfahren und zusammensetzungen zur optimierung des sauerstofftransportes in zellfreien systemenInfo
- Publication number
- ATE302019T1 ATE302019T1 AT98911428T AT98911428T ATE302019T1 AT E302019 T1 ATE302019 T1 AT E302019T1 AT 98911428 T AT98911428 T AT 98911428T AT 98911428 T AT98911428 T AT 98911428T AT E302019 T1 ATE302019 T1 AT E302019T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- oxygen
- cell
- oxygen transport
- free systems
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/41—Porphyrin- or corrin-ring-containing peptides
- A61K38/42—Haemoglobins; Myoglobins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
- Y10S530/813—Carrier is a saccharide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
- Y10S530/815—Carrier is a synthetic polymer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/810,694 US5814601A (en) | 1997-02-28 | 1997-02-28 | Methods and compositions for optimization of oxygen transport by cell-free systems |
US09/032,342 US6054427A (en) | 1997-02-28 | 1998-02-27 | Methods and compositions for optimization of oxygen transport by cell-free systems |
PCT/US1998/003846 WO1998037909A1 (en) | 1997-02-28 | 1998-02-27 | Methods and compositions for optimization of oxygen transport by cell-free systems |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE302019T1 true ATE302019T1 (de) | 2005-09-15 |
Family
ID=26708291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98911428T ATE302019T1 (de) | 1997-02-28 | 1998-02-27 | Verfahren und zusammensetzungen zur optimierung des sauerstofftransportes in zellfreien systemen |
Country Status (6)
Country | Link |
---|---|
US (5) | US6054427A (de) |
EP (1) | EP1011710B1 (de) |
JP (1) | JP4583510B2 (de) |
AT (1) | ATE302019T1 (de) |
AU (1) | AU735799C (de) |
DE (1) | DE69831248T2 (de) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69831248T2 (de) * | 1997-02-28 | 2006-04-13 | The Regents Of The University Of California, Oakland | Verfahren und zusammensetzungen zur optimierung des sauerstofftransportes in zellfreien systemen |
US20070166292A1 (en) * | 1999-04-14 | 2007-07-19 | Breonics, Inc. | System for exsanguinous metabolic support of an organ or tissue |
US6875423B1 (en) | 1999-09-21 | 2005-04-05 | Marcos Intaglietta | Methods for increasing peripheral blood circulation |
US7332320B2 (en) * | 2001-12-31 | 2008-02-19 | Genencor International, Inc. | Protease producing an altered immunogenic response and methods of making and using the same |
US20050164915A1 (en) | 2002-04-01 | 2005-07-28 | Sangart, Inc. | Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
EP1472280A4 (de) * | 2002-01-11 | 2005-09-21 | Sangart Inc | Verfahren und zusammen setzungen zum sauerstofftransport, umfassend einen sauerstoffträger und ein kristalloid in einer hypertonen lösung |
US20030153491A1 (en) * | 2002-01-11 | 2003-08-14 | Winslow Robert M. | Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
US7271145B2 (en) * | 2002-01-11 | 2007-09-18 | Sangart, Inc. | Methods and compositions for oxygen transport comprising modified hemoglobin in plasma |
SI1465643T1 (sl) | 2002-01-11 | 2008-06-30 | Sangart Inc | Postopki in sestavki za transport kisika z visokoafiniteto za kisik |
US7651797B2 (en) * | 2002-01-14 | 2010-01-26 | The Board Of Trustees Of The University Of Illinois | Electrochemical cells comprising laminar flow induced dynamic conducting interfaces, electronic devices comprising such cells, and methods employing same |
CA2377442A1 (en) * | 2002-03-20 | 2003-09-20 | Thomas Ichim | Increasing tumor oxygen content by administration of stressed cells |
DE10220992A1 (de) * | 2002-05-11 | 2003-12-04 | Sanguibiotech Ag | Verwendung eines oder mehrerer Sauerstoffträger, ausgewählt aus Hämoglobin, Myoglobin und Derivaten hiervon zur Behandlung einer Organfunktionsstörung infolge eines akuten Versorgungsmangels und zur Behandlung/Vermeidung einer Gewebeschädigung infolge einer solchen Störung |
JP3912206B2 (ja) * | 2002-07-05 | 2007-05-09 | 株式会社日立製作所 | 筒内直接燃料噴射装置用燃料ポンプ |
US20040072729A1 (en) * | 2002-10-10 | 2004-04-15 | Sunbio Inc. | High oxygen affinity PEG-hemoglobin as treatment for brain stroke |
US7217846B2 (en) * | 2002-10-31 | 2007-05-15 | Atwood Jerry L | Calixarene-based guest-host assemblies for guest storage and transfer |
US7205064B2 (en) * | 2003-06-27 | 2007-04-17 | The Board Of Trustees Of The University Of Illinois | Emulsions for fuel cells |
US20070128241A1 (en) * | 2003-10-03 | 2007-06-07 | Judith Boston | Methods, compositions, apparatuses containing tetrameric oxygen |
DE10352692A1 (de) * | 2003-11-12 | 2005-06-23 | Sanguibiotech Gmbh | Verwendung hypo-onkotischer Lösungen in das Blut addierbarer, hyperpolymerer Hämoglobine zur Behandlung eines Lungenödems |
WO2005082024A2 (en) * | 2004-02-24 | 2005-09-09 | Ini Power Systems, Inc. | Fuel cell apparatus and method of fabrication |
US20060155178A1 (en) * | 2004-03-26 | 2006-07-13 | Vadim Backman | Multi-dimensional elastic light scattering |
US20090060933A1 (en) * | 2004-06-14 | 2009-03-05 | Estell David A | Proteases producing an altered immunogenic response and methods of making and using the same |
CN101039684A (zh) * | 2004-08-31 | 2007-09-19 | 桑格特公司 | 使用氧载体组合物增强血液动力稳定性的方法 |
JP2008513962A (ja) * | 2004-09-15 | 2008-05-01 | アイエヌアイ パワー システムズ インコーポレイテッド | 電気化学電池 |
US7635530B2 (en) * | 2005-03-21 | 2009-12-22 | The Board Of Trustees Of The University Of Illinois | Membraneless electrochemical cell and microfluidic device without pH constraint |
US20070129615A1 (en) * | 2005-10-27 | 2007-06-07 | Northwestern University | Apparatus for recognizing abnormal tissue using the detection of early increase in microvascular blood content |
US9314164B2 (en) | 2005-10-27 | 2016-04-19 | Northwestern University | Method of using the detection of early increase in microvascular blood content to distinguish between adenomatous and hyperplastic polyps |
US20070179368A1 (en) * | 2005-10-27 | 2007-08-02 | Northwestern University | Method of recognizing abnormal tissue using the detection of early increase in microvascular blood content |
US20090203977A1 (en) * | 2005-10-27 | 2009-08-13 | Vadim Backman | Method of screening for cancer using parameters obtained by the detection of early increase in microvascular blood content |
US20090117207A1 (en) * | 2005-11-29 | 2009-05-07 | Zoltani Csaba K | Methods and compositions for treatment of poison-caused pathology |
US7901817B2 (en) * | 2006-02-14 | 2011-03-08 | Ini Power Systems, Inc. | System for flexible in situ control of water in fuel cells |
WO2007136555A2 (en) * | 2006-05-09 | 2007-11-29 | The United States Of America As Represented By The Secretary Of The Navy | Multifunctional blood substitute |
EP2474554A3 (de) | 2006-05-22 | 2012-10-03 | The Regents of The University of California | Zusammensetzungen und Verfahren zur Freisetzung von Sauerstoff |
US8158300B2 (en) | 2006-09-19 | 2012-04-17 | Ini Power Systems, Inc. | Permselective composite membrane for electrochemical cells |
US8551667B2 (en) * | 2007-04-17 | 2013-10-08 | Ini Power Systems, Inc. | Hydrogel barrier for fuel cells |
US20090035644A1 (en) * | 2007-07-31 | 2009-02-05 | Markoski Larry J | Microfluidic Fuel Cell Electrode System |
US8163429B2 (en) * | 2009-02-05 | 2012-04-24 | Ini Power Systems, Inc. | High efficiency fuel cell system |
AU2010258752B2 (en) | 2009-06-09 | 2015-07-09 | Prolong Pharmaceuticals, LLC | Hemoglobin compositions |
US10172950B2 (en) | 2009-06-09 | 2019-01-08 | Prolong Pharmaceuticals, LLC | Hemoglobin compositions |
US10172949B2 (en) * | 2009-06-09 | 2019-01-08 | Prolong Pharmaceuticals, LLC | Hemoglobin compositions |
AU2011220885A1 (en) | 2010-02-25 | 2012-09-06 | Sangart, Inc. | Methods for preparing PEG-hemoglobin conjugates using reduced reactant ratios |
US7989593B1 (en) | 2010-05-27 | 2011-08-02 | Bing Lou Wong | Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof |
US7932356B1 (en) | 2010-06-23 | 2011-04-26 | Bing Lou Wong | Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition |
US8048856B1 (en) | 2010-06-23 | 2011-11-01 | Billion King, Ltd. | Treatment methods using a heat stable oxygen carrier-containing pharmaceutical composition |
US8084581B1 (en) | 2011-04-29 | 2011-12-27 | Bing Lou Wong | Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus |
RU2466745C1 (ru) * | 2011-06-23 | 2012-11-20 | Учреждение Российской Академии медицинских наук институт общей реаниматологии имени В.А. Неговского РАМН | Способ улучшения газотранспортной функции донорской эритроцитарной массы длительных сроков хранения |
US20130052232A1 (en) | 2011-08-31 | 2013-02-28 | Bing Lou Wong | Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking |
EP3922643A1 (de) | 2013-01-07 | 2021-12-15 | Omniox, Inc. | Polymere formen von h-nox-proteinen |
KR102238718B1 (ko) * | 2013-03-15 | 2021-04-12 | 쉰들러, 윌리엄 | 폴리알킬렌 산화물 발레르산염 헤모글로빈 접합체 |
US20200276265A1 (en) | 2016-02-16 | 2020-09-03 | Omniox, Inc. | Modulation hypoxia associated with stroke |
US11504417B2 (en) | 2017-07-18 | 2022-11-22 | VirTech Bio, Inc. | Blood substitutes comprising hemoglobin and methods of making |
EP3836911A1 (de) | 2018-08-15 | 2021-06-23 | Omniox, Inc. | H-nox-proteine zur behandlung kardiovaskulärer und pulmonaler störungen |
Family Cites Families (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3956259A (en) * | 1973-01-30 | 1976-05-11 | Baxter Laboratories, Inc. | Fractionation of blood using block copolymer of ethylene oxide and polyoxypropylene polymer to recover fraction suitable for organ perfusate |
US3925344A (en) * | 1973-04-11 | 1975-12-09 | Community Blood Council | Plasma protein substitute |
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
DE2449885C3 (de) * | 1974-10-21 | 1980-04-30 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | Verfahren zur Herstellung von chemisch modifizierten haltbaren Hämoglobinpräparaten sowie das nach diesem Verfahren hergestellte modifizierte Hämoglobinpräparat |
US4061736A (en) * | 1975-02-02 | 1977-12-06 | Alza Corporation | Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin |
US4001401A (en) * | 1975-02-02 | 1977-01-04 | Alza Corporation | Blood substitute and blood plasma expander comprising polyhemoglobin |
US4001200A (en) * | 1975-02-27 | 1977-01-04 | Alza Corporation | Novel polymerized, cross-linked, stromal-free hemoglobin |
US4053590A (en) * | 1975-02-27 | 1977-10-11 | Alza Corporation | Compositions of matter comprising macromolecular hemoglobin |
CA1055932A (en) * | 1975-10-22 | 1979-06-05 | Hematech Inc. | Blood substitute based on hemoglobin |
GB1578776A (en) * | 1976-06-10 | 1980-11-12 | Univ Illinois | Hemoglobin liposome and method of making the same |
JPS5329908A (en) * | 1976-08-27 | 1978-03-20 | Green Cross Corp:The | Immobilized haptoglobin preparation |
US4316093A (en) * | 1979-02-12 | 1982-02-16 | International Business Machines Corporation | Sub-100A range line width pattern fabrication |
JPS6023084B2 (ja) * | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
US4650417A (en) * | 1980-01-21 | 1987-03-17 | Robert Schwartz | Denture forming device |
JPS5716815A (en) * | 1980-07-02 | 1982-01-28 | Ajinomoto Co Inc | Oxygen transporting agent for artificial blood |
US4401652A (en) * | 1980-12-31 | 1983-08-30 | Allied Corporation | Process for the preparation of stroma-free hemoglobin solutions |
JPS57206622A (en) * | 1981-06-10 | 1982-12-18 | Ajinomoto Co Inc | Blood substitute |
US4532130A (en) * | 1981-07-06 | 1985-07-30 | Rush-Presbyterian-St. Luke's Medical Center | Preparation of synthetic frythrocytes |
DE3130770C2 (de) * | 1981-08-04 | 1986-06-19 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | Verfahren zur Gewinnung von hepatitissicheren, sterilen, pyrogenfreien und stromafreien Hämoglobinlösungen |
US4473496A (en) * | 1981-09-14 | 1984-09-25 | The United States Of America As Represented By The Secretary Of The Army | Intramolecularly crosslinked hemoglobin |
DE3144705C2 (de) * | 1981-11-11 | 1983-12-08 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | Verfahren zur Herstellung eines lagerstabilen, vernetzten Hämoglobinpräparates mit hoher Sauerstoff-Transportkapazität, sowie das nach diesem Verfahren hergestellte Hämoglobinpräparat |
US4473494A (en) * | 1983-05-04 | 1984-09-25 | The United States Of America As Represented By The Secretary Of The Army | Preparation of stroma-free, non-heme protein-free hemoglobin |
US4529719A (en) * | 1983-05-04 | 1985-07-16 | Tye Ross W | Modified crosslinked stroma-free tetrameric hemoglobin |
GB8328917D0 (en) * | 1983-10-28 | 1983-11-30 | Fisons Plc | Blood substitute |
US4831012A (en) * | 1984-03-23 | 1989-05-16 | Baxter International Inc. | Purified hemoglobin solutions and method for making same |
US5281579A (en) * | 1984-03-23 | 1994-01-25 | Baxter International Inc. | Purified virus-free hemoglobin solutions and method for making same |
DE3412144A1 (de) * | 1984-03-31 | 1985-10-10 | Biotest Pharma GmbH, 6000 Frankfurt | Verfahren zur herstellung hochgereinigter, stromafreier, hepatitissicherer human- und tierhaemoglobinloesungen |
US4738952A (en) * | 1984-04-27 | 1988-04-19 | Synthetic Blood Corporation | Substitute for human blood and a method of making the same |
US4598064A (en) * | 1984-06-27 | 1986-07-01 | University Of Iowa Research Foundation | Alpha-alpha cross-linked hemoglobins |
US4600531A (en) * | 1984-06-27 | 1986-07-15 | University Of Iowa Research Foundation | Production of alpha-alpha cross-linked hemoglobins in high yield |
US4584130A (en) * | 1985-03-29 | 1986-04-22 | University Of Maryland | Intramolecularly cross-linked hemoglobin and method of preparation |
EP0206448B1 (de) * | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hämoglobin, das an ein Poly(alkenylenoxid) gebunden ist |
US5077036A (en) * | 1986-01-14 | 1991-12-31 | Alliance Pharmaceutical Corp. | Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid |
US4987154A (en) * | 1986-01-14 | 1991-01-22 | Alliance Pharmaceutical Corp. | Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use |
US5080885A (en) * | 1986-01-14 | 1992-01-14 | Alliance Pharmaceutical Corp. | Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport |
US5684050A (en) * | 1986-01-24 | 1997-11-04 | Hemagen/Pfc | Stable emulsions of highly fluorinated organic compounds |
US4826811A (en) * | 1986-06-20 | 1989-05-02 | Northfield Laboratories, Inc. | Acellular red blood cell substitute |
US5464814A (en) * | 1986-06-20 | 1995-11-07 | Northfield Laboratories, Inc. | Acellular red blood cell substitute |
US5194590A (en) * | 1986-06-20 | 1993-03-16 | Northfield Laboratories, Inc. | Acellular red blood cell substitute |
US4911929A (en) * | 1986-08-29 | 1990-03-27 | The United States Of America As Represented By The Secretary Of The Navy | Blood substitute comprising liposome-encapsulated hemoglobin |
US4710417A (en) * | 1986-09-26 | 1987-12-01 | Corra-Board Products Co., Inc. | Paperboard panel construction |
US4730936A (en) * | 1986-10-10 | 1988-03-15 | The United States Of America As Represented By The Secretary Of The Air Force | Gas driven system for preparing large volumes of non-oxidized, pyridoxylated, polymerized stroma-free hemoglobin solution for use as a blood substitute |
DE3636590A1 (de) * | 1986-10-28 | 1988-05-26 | Braun Melsungen Ag | Blutersatzmittel |
CA1312009C (en) * | 1986-11-10 | 1992-12-29 | Carl W. Rausch | Extra pure semi-synthetic blood substitute |
US5084558A (en) * | 1987-10-13 | 1992-01-28 | Biopure Corporation | Extra pure semi-synthetic blood substitute |
GB8710598D0 (en) * | 1987-05-05 | 1987-06-10 | Star Medical Diagnostics Ltd | Hemoglobin based blood substitute |
GB8711614D0 (en) * | 1987-05-16 | 1987-06-24 | Medical Res Council | Proteins |
US5449759A (en) * | 1987-05-16 | 1995-09-12 | Somatogen, Inc. | Hemoglobins with intersubunit desulfide bonds |
US4861867A (en) * | 1988-02-03 | 1989-08-29 | Baxter International, Inc. | Purified hemoglobin solutions and method for making same |
US4900780A (en) * | 1988-05-25 | 1990-02-13 | Masonic Medical Research Laboratory | Acellular resuscitative fluid |
CA1338244C (en) * | 1988-08-17 | 1996-04-09 | Xiang-Fu Wu | Purification of hemoglobin and methemoglobin by bioselective elution |
US5061688A (en) * | 1988-08-19 | 1991-10-29 | Illinois Institute Of Technology | Hemoglobin multiple emulsion |
IL87707A (en) * | 1988-09-08 | 1994-06-24 | Technion Inst For Research And | Hemoglobin-based blood substitute substantially similar to human blood and method for preparation thereof |
US5128452A (en) * | 1989-04-19 | 1992-07-07 | Baxter International Inc. | Process for the production of crosslinked hemoglobin in the presence of sodium tripolyphosphate |
US5545727A (en) * | 1989-05-10 | 1996-08-13 | Somatogen, Inc. | DNA encoding fused di-alpha globins and production of pseudotetrameric hemoglobin |
NL8901174A (nl) * | 1989-05-10 | 1990-12-03 | Het Hoofd Van De Afdeling Mili | Hemoglobine-preparaat en gebruik daarvan. |
US5599907A (en) * | 1989-05-10 | 1997-02-04 | Somatogen, Inc. | Production and use of multimeric hemoglobins |
US5650388A (en) * | 1989-11-22 | 1997-07-22 | Enzon, Inc. | Fractionated polyalkylene oxide-conjugated hemoglobin solutions |
US5478806A (en) * | 1989-11-22 | 1995-12-26 | Enzon, Inc. | Enhancement of antitumor therapy with hemoglobin-based conjugates |
US5312808A (en) * | 1989-11-22 | 1994-05-17 | Enzon, Inc. | Fractionation of polyalkylene oxide-conjugated hemoglobin solutions |
US5386014A (en) * | 1989-11-22 | 1995-01-31 | Enzon, Inc. | Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood cell substitute |
US5234903A (en) * | 1989-11-22 | 1993-08-10 | Enzon, Inc. | Chemically modified hemoglobin as an effective, stable non-immunogenic red blood cell substitute |
US5041615A (en) * | 1989-12-05 | 1991-08-20 | Baxter International Inc. | Preparation of bis(salicyl) diesters |
JP2999815B2 (ja) * | 1990-04-24 | 2000-01-17 | テルモ株式会社 | 人工血液 |
JP3085963B2 (ja) * | 1990-04-24 | 2000-09-11 | テルモ株式会社 | 人工血液 |
US5239061A (en) * | 1990-06-20 | 1993-08-24 | Research Corporation Technologies, Inc. | Modified human hemoglobin, blood substitutes containing the same, and vectors for expressing the modified hemoglobin |
US5352773A (en) * | 1990-08-06 | 1994-10-04 | Baxter International Inc. | Stable hemoglobin based composition and method to store same |
US5248766A (en) * | 1990-08-17 | 1993-09-28 | Baxter International Inc. | Oxirane-modified hemoglobin based composition |
FR2666506A1 (fr) * | 1990-09-07 | 1992-03-13 | Pf Medicament | Comprime a liberation prolongee a base de 5-mononitrate d'isosorbide et son procede de preparation. |
US5252714A (en) | 1990-11-28 | 1993-10-12 | The University Of Alabama In Huntsville | Preparation and use of polyethylene glycol propionaldehyde |
US5114932A (en) * | 1990-11-30 | 1992-05-19 | Runge Thomas M | Hyperosmolar oxyreplete hemosubstitute |
JPH04300838A (ja) * | 1991-03-28 | 1992-10-23 | Terumo Corp | 人工赤血球および人工赤血球懸濁液 |
CA2066374C (en) * | 1991-04-19 | 2002-01-29 | Paul E. Segall | Solution for perfusing primates |
US5295944A (en) * | 1991-05-14 | 1994-03-22 | Dana-Farber Cancer Institute | Method for treating a tumor with ionizing radiation |
US5250665A (en) * | 1991-05-31 | 1993-10-05 | The University Of Toronto Innovations Foundation | Specifically β-β cross-linked hemoglobins and method of preparation |
US5334705A (en) * | 1991-08-15 | 1994-08-02 | Duke University | Benzenetricarboxylate derivative-crosslinked low oxygen affinity hemoglobin |
US5349054A (en) * | 1991-08-15 | 1994-09-20 | Duke University | Activated benzenepentacarboxylate-crosslinked low oxygen affinity hemoglobin |
US5334706A (en) * | 1992-01-30 | 1994-08-02 | Baxter International | Administration of low dose hemoglobin to increase perfusion |
US5200323A (en) * | 1992-01-31 | 1993-04-06 | Mcgill University | In vitro method to determine the safety of modified hemoglobin blood substitutes for human prior to clinical use |
US5296466A (en) * | 1992-02-19 | 1994-03-22 | Board Of Regents, The University Of Texas System | Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein |
US5344393A (en) * | 1992-02-28 | 1994-09-06 | Alliance Pharmaceutical Corp. | Use of synthetic oxygen carriers to facilitate oxygen delivery |
US5264555A (en) * | 1992-07-14 | 1993-11-23 | Enzon, Inc. | Process for hemoglobin extraction and purification |
US5628930A (en) * | 1992-10-27 | 1997-05-13 | Alliance Pharmaceutical Corp. | Stabilization of fluorocarbon emulsions |
US5558855A (en) * | 1993-01-25 | 1996-09-24 | Sonus Pharmaceuticals | Phase shift colloids as ultrasound contrast agents |
US5635538A (en) * | 1993-03-16 | 1997-06-03 | Alliance Pharmaceutical Corp. | Fluorocarbon emulsions with reduced pulmonary gas-trapping properties |
NZ262349A (en) * | 1993-03-16 | 1996-05-28 | Hemosol Inc | Chemically modifying haemoglobin by crosslinking with a polyaldehyde produced by ring opening oxidation of a saccharide; for use in a blood substitute |
US5554638A (en) * | 1993-05-24 | 1996-09-10 | Duke University | Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders |
WO1994028950A1 (en) * | 1993-06-04 | 1994-12-22 | Biotime, Inc. | Plasma-like solution |
US5407428A (en) * | 1993-06-04 | 1995-04-18 | Biotime, Inc. | Solutions for use as plasma expanders and substitutes |
US5578564A (en) * | 1993-07-23 | 1996-11-26 | Somatogen, Inc. | Nickel-free hemoglobin and methods for producing such hemoglobin |
TW381022B (en) * | 1993-08-16 | 2000-02-01 | Hsia Jen Chang | Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute |
US5545328A (en) * | 1993-09-21 | 1996-08-13 | Hemosol Inc. | Purification of hemoglobin by displacement chromatography |
CA2106612C (en) * | 1993-09-21 | 2001-02-06 | Diana Pliura | Displacement chromatography process |
US5631219A (en) * | 1994-03-08 | 1997-05-20 | Somatogen, Inc. | Method of stimulating hematopoiesis with hemoglobin |
US5585484A (en) * | 1995-04-19 | 1996-12-17 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | Hemoglobin crosslinkers |
US5525630A (en) * | 1995-06-01 | 1996-06-11 | Allos Therapeutics, Inc. | Treatment for carbon monoxide poisoning |
DE69831248T2 (de) * | 1997-02-28 | 2006-04-13 | The Regents Of The University Of California, Oakland | Verfahren und zusammensetzungen zur optimierung des sauerstofftransportes in zellfreien systemen |
US5814601A (en) * | 1997-02-28 | 1998-09-29 | The Regents Of The University Of California | Methods and compositions for optimization of oxygen transport by cell-free systems |
US5985825A (en) * | 1998-02-28 | 1999-11-16 | The Regents Of The University Of California | Methods and compositions for optimization of oxygen transport by cell-free systems |
-
1998
- 1998-02-27 DE DE69831248T patent/DE69831248T2/de not_active Expired - Lifetime
- 1998-02-27 AT AT98911428T patent/ATE302019T1/de not_active IP Right Cessation
- 1998-02-27 US US09/032,342 patent/US6054427A/en not_active Expired - Lifetime
- 1998-02-27 JP JP53788098A patent/JP4583510B2/ja not_active Expired - Fee Related
- 1998-02-27 AU AU65381/98A patent/AU735799C/en not_active Ceased
- 1998-02-27 EP EP98911428A patent/EP1011710B1/de not_active Expired - Lifetime
-
2000
- 2000-04-05 US US09/544,656 patent/US6432918B1/en not_active Expired - Fee Related
-
2002
- 2002-07-18 US US10/199,269 patent/US20030083233A1/en not_active Abandoned
-
2004
- 2004-08-11 US US10/917,223 patent/US7101846B2/en not_active Expired - Fee Related
-
2005
- 2005-01-11 US US11/034,457 patent/US20050239686A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US6054427A (en) | 2000-04-25 |
AU735799B2 (en) | 2001-07-12 |
US20050009736A1 (en) | 2005-01-13 |
EP1011710A1 (de) | 2000-06-28 |
US6432918B1 (en) | 2002-08-13 |
EP1011710A4 (de) | 2004-03-31 |
EP1011710B1 (de) | 2005-08-17 |
JP2002514207A (ja) | 2002-05-14 |
US7101846B2 (en) | 2006-09-05 |
AU6538198A (en) | 1998-09-18 |
US20050239686A1 (en) | 2005-10-27 |
DE69831248D1 (de) | 2005-09-22 |
AU735799C (en) | 2005-04-28 |
US20030083233A1 (en) | 2003-05-01 |
DE69831248T2 (de) | 2006-04-13 |
JP4583510B2 (ja) | 2010-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE302019T1 (de) | Verfahren und zusammensetzungen zur optimierung des sauerstofftransportes in zellfreien systemen | |
CA2282407A1 (en) | Methods and compositions for optimization of oxygen transport by cell-free systems | |
ATE363357T1 (de) | Werkzeug zur feinstbearbeitung von oberflächen | |
HK1036994A1 (en) | Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof | |
BR0012243A (pt) | Triflúor butenos nematocidas | |
NO990674D0 (no) | Oksygen-inaktiverende flerkomponentblanding og anvendelse derav i plastgjenstander | |
DE60318388D1 (de) | Verfahren und zusammensetzungen zum sauerstofftransport mit hoher sauerstoffaffinität | |
ATE392430T1 (de) | Verfahren zur herstellung von dipeptiden | |
EP0656886A1 (de) | N-(alkanoylamino-2-hydroxypropyl)-sulfonamide verwendbar als retrovirale proteaseninhibitoren. | |
ZA919161B (en) | Retroviral protease inhibitors. | |
DE69131589T2 (de) | Ribosomen-inaktivierende Proteine, inaktive Vorläuferformen derselben, Verfahren zur Herstellung und eine Methode zur Nutzung | |
GR3034894T3 (en) | Retroviral protease inhibitors | |
ATE449104T1 (de) | Verfahren zur reinigung von fibrinogen | |
YU16399A (sh) | ) UPOTREBA INHIBITOR H +, K+ - ATP- aze I FARMACEUTSKA FORMULACIJA ZA SIMULTANU, SEPARATNU ILI SEKVENCIJALNU UPOTREBU, KOJA SADRZI INHIBITOR H +, K+-ATP- aze I GLUKOKORTIKOID INHIBITOR H +, K+- ATP- aze | |
DE69521126D1 (de) | Verfahren und vorrichtung zur kontinuierliche mahlen von aerosol pharmazeutische formulierungen un aerosol treibgasen | |
ES2195586T3 (es) | Almidon modificado, estable respecto a la sal. | |
BR0311379A (pt) | Método para preparar um aditivo alimentìcio, aditivo alimentìcio, uso do mesmo, e, produto alimentìcio | |
ES2100863T3 (es) | Procedimiento para la preparacion de acidos nucleicos modificados. | |
AU2001280093A1 (en) | Method for the prevention and treatment of retinopathy | |
ATE364607T1 (de) | Verfahren zur produktion von 2,6- dihalogenopurinen | |
DE69425149D1 (de) | Verfahren und mittel für die herstellung von bindungsproteinen für inhibitoren von plasmaproteinasen | |
AU4317897A (en) | Pharmaceutical compositions comprising s-alkylisothiouronium derivatives | |
DE50310123D1 (de) | Vorrichtung zur aufbewahrung und zum transport von stückgut sowie einlage hierfür | |
ATE376586T1 (de) | Ppgpp-synthetase und expressionssysteme zur verbesserten herstellung von proteinen | |
GR3023044T3 (en) | Succinoylamino hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |